» Articles » PMID: 18560558

Critical Involvement of the ATM-dependent DNA Damage Response in the Apoptotic Demise of HIV-1-elicited Syncytia

Abstract

DNA damage can activate the oncosuppressor protein ataxia telangiectasia mutated (ATM), which phosphorylates the histone H2AX within characteristic DNA damage foci. Here, we show that ATM undergoes an activating phosphorylation in syncytia elicited by the envelope glycoprotein complex (Env) of human immunodeficiency virus-1 (HIV-1) in vitro. This was accompanied by aggregation of ATM in discrete nuclear foci that also contained phospho-histone H2AX. DNA damage foci containing phosphorylated ATM and H2AX were detectable in syncytia present in the brain or lymph nodes from patients with HIV-1 infection, as well as in a fraction of blood leukocytes, correlating with viral status. Knockdown of ATM or of its obligate activating factor NBS1 (Nijmegen breakage syndrome 1 protein), as well as pharmacological inhibition of ATM with KU-55933, inhibited H2AX phosphorylation and prevented Env-elicited syncytia from undergoing apoptosis. ATM was found indispensable for the activation of MAP kinase p38, which catalyzes the activating phosphorylation of p53 on serine 46, thereby causing p53 dependent apoptosis. Both wild type HIV-1 and an HIV-1 mutant lacking integrase activity induced syncytial apoptosis, which could be suppressed by inhibiting ATM. HIV-1-infected T lymphoblasts from patients with inactivating ATM or NBS1 mutations also exhibited reduced syncytial apoptosis. Altogether these results indicate that apoptosis induced by a fusogenic HIV-1 Env follows a pro-apoptotic pathway involving the sequential activation of ATM, p38MAPK and p53.

Citing Articles

Autophagy and Programmed Cell Death Modalities Interplay in HIV Pathogenesis.

Lamsira H, Sabatini A, Ciolfi S, Ciccosanti F, Sacchi A, Piacentini M Cells. 2025; 14(5).

PMID: 40072080 PMC: 11899401. DOI: 10.3390/cells14050351.


Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer.

Juncheng P, Joseph A, Lafarge A, Martins I, Obrist F, Pol J J Immunother Cancer. 2022; 10(6).

PMID: 35772809 PMC: 9247697. DOI: 10.1136/jitc-2021-004280.


Distinct Oncogenic Transcriptomes in Human Mammary Epithelial Cells Infected With Cytomegalovirus.

Haidar Ahmad S, Pasquereau S, El Baba R, Nehme Z, Lewandowski C, Herbein G Front Immunol. 2022; 12:772160.

PMID: 35003089 PMC: 8727587. DOI: 10.3389/fimmu.2021.772160.


Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation.

Beraud C, Lemaire M, Perez Bercoff D Virol J. 2018; 15(1):35.

PMID: 29454367 PMC: 5816530. DOI: 10.1186/s12985-018-0941-7.


HIV-1 Tat potently stabilises Mdm2 and enhances viral replication.

Raja R, Ronsard L, Lata S, Trivedi S, Banerjea A Biochem J. 2017; 474(14):2449-2464.

PMID: 28468838 PMC: 5509382. DOI: 10.1042/BCJ20160825.


References
1.
Dupre A, Boyer-Chatenet L, Gautier J . Two-step activation of ATM by DNA and the Mre11-Rad50-Nbs1 complex. Nat Struct Mol Biol. 2006; 13(5):451-7. DOI: 10.1038/nsmb1090. View

2.
Porras O, Pelaez B, Pacheco-Castro A, Gatti R, Regueiro J . Membrane and transmembrane signaling in Herpesvirus saimiri-transformed human CD4(+) and CD8(+) T lymphocytes is ATM-independent. Int Immunol. 2000; 12(6):927-35. DOI: 10.1093/intimm/12.6.927. View

3.
Difilippantonio S, Celeste A, Kruhlak M, Lee Y, Difilippantonio M, Feigenbaum L . Distinct domains in Nbs1 regulate irradiation-induced checkpoints and apoptosis. J Exp Med. 2007; 204(5):1003-11. PMC: 2118591. DOI: 10.1084/jem.20070319. View

4.
Lum J, Cohen O, Nie Z, Weaver J, Gomez T, Yao X . Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest. 2003; 111(10):1547-54. PMC: 155040. DOI: 10.1172/JCI16233. View

5.
Yao X, Mouland A, Subbramanian R, Forget J, Rougeau N, Bergeron D . Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. J Virol. 1998; 72(6):4686-93. PMC: 109992. DOI: 10.1128/JVI.72.6.4686-4693.1998. View